Skip to content

UK doctors urge caution over maternal nevirapine use in developed world

Adjusting methadone dosage on efavirenz: how much and when to do it

Induction-maintenance strategy fails

Dating of HIV origin to 1930 is flawed, says Hooper

Toxoplasmosis, cryptococcus: safe to stop maintenance treatment after CD4 rise

No advantage to starting therapy at CD4 count above 200: cohort evidence challenges conventional wisdom

Cheaper treatment for diarrhoea, but pneumococcal vaccine useless in Africa

Post-AIDS, but not post-HIV in the North: a report from the AIDS Impact conference

Hydroxyurea debate revives: suitable drug for poor nations?

Can the immune system be rebuilt?

More than 50% ready for treatment as soon as they test HIV+

1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals

News from the British HIV Association Fifth Annual Meeting

Atlantic study shows PI-sparing combos match indinavir after 48 weeks

Adefovir rejected for US license

40% of French combo patients have detectable viral load

Efavirenz side effects become long-term for over one in three

Virgin Islands conference summaries